Feb 22, 2021
Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021
Feb 04, 2021
Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021
Jan 07, 2021
Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency
Dec 17, 2020
Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug
Dec 02, 2020
Medicure Retains Investor Relations Firm Renmark Financial Communications Inc.
Nov 18, 2020
Medicure Announces Settlement of Patent Infringement Action
Nov 11, 2020
Medicure Reports Financial Results for Quarter Ended September 30, 2020
Nov 05, 2020
Medicure Q3 2020 Results and Conference Call Dates
Oct 05, 2020
Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar
Aug 24, 2020
Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
Aug 20, 2020
Medicure Announces Termination of ReDSTM Pro Marketing and Distribution Agreement
Aug 11, 2020
Medicure Reports Financial Results for Quarter Ended June 30, 2020
Aug 05, 2020
Medicure Q2 2020 Results and Conference Call Dates
Jun 29, 2020
Medicure Announces Normal Course Issuer Bid
Jun 29, 2020
Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER Trial and Publication in the Journal - Circulation
Jun 25, 2020
Medicure Announces a Direct to Patient Online Pharmacy Program for Distribution of ZYPITAMAG(TM) (Pitavastatin) Tablets
Jun 15, 2020
Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020
May 12, 2020
Medicure Reports Financial Results for Quarter Ended March 31, 2020
May 06, 2020
Medicure Q1 2020 results and conference call dates
Apr 15, 2020
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2019